Affinity-purified soluble FcϵRII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanism

This publication has 17 references indexed in Scilit:

• CD23: a multi-functional receptor/ lymphokine?
  Immunology Today, 1989
• The B-cell binding site on human immunoglobulin E
  Nature, 1989
• Interleukin 5 enhances interleukin 4‐induced IgE production by normal human B cells. The role of soluble CD23 antigen
  European Journal of Immunology, 1988
• Histamine-releasing factors and IgE heterogeneity
  Journal of Allergy and Clinical Immunology, 1988
• Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)
  European Journal of Immunology, 1988
• The mast cell binding site on human immunoglobulin E
  Nature, 1988
• Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE‐binding factor analogous to that spontaneously released by lymphoblastoid B cell lines
  European Journal of Immunology, 1988
• Use of synthetic peptides in the production and characterization of antibodies directed against predetermined specificities in rat immunoglobulin E
  Molecular Immunology, 1986
• Changes in cellular levels of cyclic AMP in rat mast cells during secretion of histamine induced by immunoglobulin E decapeptide and ACTH(1–24) peptide
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1983
• An automated fluorimetric assay for the rapid determination of histamine in biological fluids
  Life Sciences, 1973